icon-    folder.gif   Conference Reports for NATAP  
  Back grey_arrow_rt.gif
the PARTNER Study: new results from PARTNER 2 - PDF - Q and A
  Download the PDF
PARTNER 2 study reports zero HIV transmissions over eight years in gay men not using condoms: an undetectable viral load on HIV treatment renders an individual sexually non-infectious
On 25 July 2018, late-breaking results presented at the AIDS 2018 conference in Amsterdam, confirm that having an undetectable viral load is as protective for gay men as it is for heterosexual couples. This will improve the quality of life for HIV positive people and their partners globally.
This is the largest study to look at the risk of HIV transmission when the positive partner in on effective treatment (ART).

The PARTNER2 Study has been following almost 1,000 gay male serodifferent couples from 14 different countries in Europe, where one partner was HIV-infected and on suppressive ART, and the other partner was HIV-negative. The study followed couples from September 2010 to April 2018, over which time couples reported almost 77,000 episodes of condomless anal sex with no linked HIV transmission occurring.
Dr Alison Rodger from UCL, London (lead author on the PARTNER study) explains the study: "The PARTNER2 study was designed to find whether HIV transmission occurs in gay men when viral load was suppressed.
Despite these couples having sex without condoms almost 77,000 times we did not find a single case.
PARTNER2 data provides robust evidence for gay men that the risk of HIV transmission with suppressive ART is effectively zero, supporting the message of the U=U campaign."

PARTNER2 was an extension of the earlier PARTNER1 study, which also found zero transmissions in a study population where 65% of couples were heterosexual. Some gay couples in PARTNER2 were also included in the PARTNER 1 results.
The new results provide a similar level of confidence that HIV transmission risk in gay men through condomless sex is effectively zero as PARTNER1 provided for heterosexual couples.
The results underline the importance of earlier diagnosis and treatment.
Professor Jens Lundgren, professor in Infectious Diseases at Rigshospitalet, University of Copenhagen and Co-PI for the PARTNER study, comments "In 2015 we proved that it was better to start HIV treatment as soon as possible. We have now provided the scientific evidence for how effectively treatment prevents further sexual transmission".
No linked HIV transmissions between serodifferent gay couples in the study
Some of the originally HIV negative men did becomes positive during the study, but by comparing the structure of each virus it was possibile to show that the two infections were different, and to conclude that the new infection was not acquired from the HIV positive partner. This uses a technique called phylogenetic analysis.
In the PARTNER2 study, a total of 15 HIV-negative gay men became HIV positive during follow up.
Researchers from the University of Liverpool led by Professor Anna Maria Geretti, undertook the phylogenetic analyses. Professor Geretti comments: "Each individual HIV infection has its own genetic characteristics. Comparing the genomes of different viruses can show how similar or indeed dissimilar one virus is to another. In PARTNER2, the phylogenetic analysis showed that in all cases of new HIV infections occurring during the study, the virus was so different that it must have come from someone other than the HIV-positive partner on suppressive ART."
Simon Collins, an HIV positive treatment activist at HIV i-Base, London, and one of the community representatives involved in the study said: "PARTNER2 has met the community demand from gay men to have accurate data about our health. There is no evidence that HIV transmission can actually occur when viral load is undetectable. Our data continue to support the international U=U awareness campaign."
Press contact:
Alison Rodger: Alison.rodger@ucl.ac.uk [+44 (0) 203 108 8515] Jens Lundgren: jens.lundgren@regionh.dk [+45 40879303]
About the PARTNER study<

The PARTNER study was an observational study focusing on the risk of sexual HIV transmission when an HIV positive person is on treatment.
The second phase enrolled gay male couples in which one partner was HIV positive and the other was HIV negative. It only enrolled couples that had already chosen not to use condoms on a regular basis when they entered the study.
To be eligible for PARTNER2, the HIV positive person needed to be on HIV treatment (ART) at the time of enrolment. Participants also completed questionnaires every six months describing how often they had sex.
Clinical data with HIV viral load monitoring of the HIV positive partner and HIV testing of the negative partner was also carried out every 6-12 months.
The PARTNER study was set up to address a question of great relevance in the daily life of people living with HIV and was conducted in collaboration with representatives of HIV organisations in an effort to make the study as close as possible to participants and to the larger community of people living with HIV.
The second phase of PARTNER was funded by the National Institute of Health Research UK, ViiV Healthcare, Gilead Sciences, Augustinus Fonden and A.P. Moller Fonden and is sponsored by CHIP, Rigshospitalet.
Additionally, funding for participation of the Swiss centres has been provided by the Swiss Office of Public Health. The study is coordinated cooperatively between CHIP, Rigshospitalet, University of Copenhagen, and University College London.